Trial
NCT01045928
Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Case Comprehensive Cancer Center
Collaborators
—
Condition
Adult Non-Hodgkin Lymphoma
Intervention
lenalidomide
Why stopped
Extreme toxicity in Phase I, study did not proceed to Phase II
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-11-26